Lataa...
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
While the world is facing the urgency of the COVID-19 pandemic, policymakers must plan for the direct response to the outbreak while minimising its collateral impact. Maintaining the supply chain of pharmaceutical products is not only paramount to cover the immediate medical response but will be fun...
Tallennettuna:
| Julkaisussa: | F1000Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
F1000 Research Limited
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7284150/ https://ncbi.nlm.nih.gov/pubmed/32566139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.23057.1 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|